NCT07398521 is a NA clinical trial of Liposomal Magnesium Complex in Mood, sponsored by Cymbiotika, LLC.

Who is sponsoring NCT07398521?

NCT07398521 is sponsored by Cymbiotika, LLC.

What drugs are being tested in NCT07398521?

Interventions in NCT07398521: Liposomal Magnesium Complex.

What condition does NCT07398521 study?

NCT07398521 studies Mood, Stress.

Is NCT07398521 still recruiting?

NCT07398521 is currently completed. Last updated 10 February 2026.

Last reviewed 2026-02-10 · How we verify

NCT07398521

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial to Evaluate the Effects of a Supplement on Energy and Mood

Completed NA Last updated 10 February 2026

What this trial tests

NA trial testing Liposomal Magnesium Complex in Mood in 60 participants. Completed in 8 December 2025.

Timeline

14 October 2025

Primary endpoint
8 December 2025

8 December 2025

Quick facts

Lead sponsor	Cymbiotika, LLC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	14 October 2025
Primary completion	8 December 2025
Estimated completion	8 December 2025
Sites	1 location across United States

Drugs / interventions tested

Liposomal Magnesium Complex

Conditions studied

Mood — all drugs for Mood →
Stress — all drugs for Stress →

Sponsor

Cymbiotika, LLC

Who can join

Adults 18 to 60, any sex, with Mood or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mood

Currently open trials in the same condition.

NCT07228013 — Examining Effects of Active Plant Engagement on College Student Well-Being and Performance · NA · active not recruiting
NCT07017023 — Combined Blood Pressure Medication and Activity Scheduling for Low Mood · EARLY_PHASE1 · recruiting
NCT07033052 — Developing Resilience and Anxiety Management Through the Arts · NA · recruiting
NCT06950424 — Effect of Black Cumin Seed Oil Supplementation on Cortisol, Stress and Mood · NA · active not recruiting
NCT06716554 — Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, P · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07398521 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cymbiotika, LLC
Last refreshed: 10 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07398521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing